Cowealth Medical China Stock Current Valuation
| 603122 Stock | 7.03 0.20 2.77% |
Valuation analysis of Cowealth Medical China helps investors to measure Cowealth Medical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At present, Cowealth Medical's Change In Cash is projected to increase significantly based on the last few years of reporting. The current year's Free Cash Flow is expected to grow to about 106 M, whereas Cash is forecasted to decline to about 226.5 M. Fundamental drivers impacting Cowealth Medical's valuation include:
Price Book 2.3887 | Enterprise Value 2.6 B | Enterprise Value Ebitda 48.7107 | Price Sales 2.9797 | Trailing PE 100.4286 |
Overvalued
Today
Please note that Cowealth Medical's price fluctuation is somewhat reliable at this time. Calculation of the real value of Cowealth Medical China is based on 3 months time horizon. Increasing Cowealth Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Cowealth Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cowealth Stock. However, Cowealth Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 7.03 | Real 6.0 | Hype 7.04 | Naive 7.16 |
The real value of Cowealth Stock, also known as its intrinsic value, is the underlying worth of Cowealth Medical China Company, which is reflected in its stock price. It is based on Cowealth Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Cowealth Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Cowealth Medical China helps investors to forecast how Cowealth stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cowealth Medical more accurately as focusing exclusively on Cowealth Medical's fundamentals will not take into account other important factors: Cowealth Medical China Company Current Valuation Analysis
Cowealth Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Cowealth Medical Current Valuation | 2.59 B |
Most of Cowealth Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cowealth Medical China is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Cowealth Medical China has a Current Valuation of 2.59 B. This is 81.97% lower than that of the Biotechnology sector and 66.79% lower than that of the Health Care industry. The current valuation for all China stocks is 84.42% higher than that of the company.
Cowealth Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cowealth Medical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cowealth Medical could also be used in its relative valuation, which is a method of valuing Cowealth Medical by comparing valuation metrics of similar companies.Cowealth Medical is currently under evaluation in current valuation category among its peers.
Cowealth Fundamentals
| Return On Equity | 0.0243 | ||||
| Return On Asset | 0.0153 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | (0.01) % | ||||
| Current Valuation | 2.59 B | ||||
| Shares Outstanding | 398.05 M | ||||
| Shares Owned By Insiders | 57.57 % | ||||
| Shares Owned By Institutions | 0.63 % | ||||
| Price To Book | 2.39 X | ||||
| Price To Sales | 2.98 X | ||||
| Revenue | 939.14 M | ||||
| Gross Profit | 184.09 M | ||||
| EBITDA | 44.69 M | ||||
| Net Income | 27.57 M | ||||
| Total Debt | 46.27 M | ||||
| Book Value Per Share | 2.68 X | ||||
| Cash Flow From Operations | 132.75 M | ||||
| Earnings Per Share | 0.07 X | ||||
| Beta | 0.55 | ||||
| Market Capitalization | 2.8 B | ||||
| Total Asset | 1.49 B | ||||
| Retained Earnings | 129.31 M | ||||
| Working Capital | 972.28 M | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 1.49 B |
About Cowealth Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cowealth Medical China's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cowealth Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cowealth Medical China based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Cowealth Stock
Cowealth Medical financial ratios help investors to determine whether Cowealth Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cowealth with respect to the benefits of owning Cowealth Medical security.